Camden National director receives stock grant
Camden National Corp director Larry K. Haynes received a stock grant as part of his board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Camden National Corp director Larry K. Haynes received a stock grant as part of his board compensation. On 2026-06-18, he acquired 279 shares of common stock at $51.49 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
Following this grant, Haynes directly holds 1,198 common shares and indirectly holds 3,217.888 common shares through a revocable trust. This reflects a routine, compensation-related equity award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 279 | $51.49 | $14K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
Key Figures
Key Terms
2022 Equity and Incentive Plan and Amendment financial
Revocable Trust financial
Grant, award, or other acquisition financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Camden National (CAC) director Larry K. Haynes report on this Form 4?
At what price was the Camden National (CAC) stock grant to Larry K. Haynes valued?
Was the Camden National (CAC) Form 4 transaction a market buy or sell?
What plan governed Larry K. Haynes’s Camden National (CAC) stock grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.